Clinical studies recruiting near Vienna

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Nitrate, Exercise and Vascular Function in Midlife Women
NA · University of Vienna · University of Vienna · NCT06527248 Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Artery
NA · Medical University of Vienna · Medical University Innsbruck · NCT05931783 Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 0400001 · Sanofi · NCT06867094 Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Phase N/A · Medical University of Vienna, Department of Medicine 1, Div. · Insel Gruppe AG, University Hospital Bern · NCT01257269 Austrian PBC Registry
Phase N/A · Klinik Landstraße · Medical University of Vienna · NCT07598669 Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or
Phase 3 · Medical University Vienna · CSL Behring · NCT07080905 A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Phase 2/Phase 3 · St. Anna Children's Hospital · University of Birmingham · NCT05991388 A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients Wit
Phase 1 · Medizinische Universität Wien · eleva GmbH · NCT07483827 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · St. Anna Children's Hospital · Princess Maxima Center for Pediatric Oncology · NCT05327894 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Medizinische Universität Wien · Bristol-Myers Squibb · NCT07106762 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Medizinische Universität Wien-Universitätsklinik für Innere · Merck Sharp & Dohme LLC · NCT06393374 Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma Investigational Site 7079 · Galderma R&D · NCT06988605 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Medizinische Universität Wien · Pfizer · NCT06758401 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Medizinische Universitaet Wien - Allgemeines Krankenhaus der · Miltenyi Biomedicine GmbH · NCT04844866 The DRAGON 2 Trial
NA · Social Medical Center, South · Maastricht University · NCT05428735 STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06960213 Safety and Early Efficacy of Radical Prostatectomy for Newly Diagnosed Very High Risk Locally Advanced and Oligometastat
NA · Medical University of Vienna · Medical University of Vienna · NCT02971358 First-In-Human Clinical Study for Treatment of Severe Mitral Valve INsufficiency With Epygon™ TRanscatheter Mitral VAlve
NA · Medical University of Vienna - Department of Surgery, Divisi · Epygon · NCT04775108 The Medacta International SMS Post-Marketing Surveillance Study
Phase N/A · Herz-Jesu Krankenhaus · Medacta International SA · NCT02748408 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Sankt Anna-Kinderspital · PedAL BCU, LLC · NCT05183035 Randomization of Single vs Multiple Arterial Grafts
NA · Krankenhaus Nord Vienna North Hospital · Weill Medical College of Cornell University · NCT03217006 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Klinik Landstrasse · Amgen · NCT07037433 PERCEPTION - Super-Early Neuroprognostication in eCPR Patients
Phase N/A · Department of Emergency Medicine, Medical University of Vien · Medical University of Vienna · NCT07584187 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Medizinische Universitaet Wien ( Site 0302) · Merck Sharp & Dohme LLC · NCT07216703 Intelligent Vacuum Assisted Biopsy Immediately Before Surgery As an Intra- or Pre-Operative Surrogate for Patient Respon
NA · St. Josef Krankenhaus Wien · Klinik Hirslanden, Zurich · NCT04289935 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · Klinik Landstrasse, Kardiologie · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 Efficacy of Torque Teno Virus as a Biomarker for Predicting Treatment Response of Immune Checkpoint Inhibitor Therapy an
Phase N/A · Medical University of Vienna · Medical University of Vienna · NCT06967532 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Klinik Floridsdorf · Eli Lilly and Company · NCT06890598

Look up another city

Look up another condition